Press Releases
Endo International has persuaded Auxilium Pharma into a takeover that leaves an earlier plan to merge Auxilium with QLT in tatters.
Ireland-based Endo has made a $2.6bn cash-and-stock offer for Auxilium - which has been approved by the boards of both companies - that will add the latter's portfolio of testosterone replacement therapies to Endo fast-growing speciality pharma business. ...
Press Releases
Pharming and Swedish Orphan Biovitrum Amend and Extend Ruconest Distribution Agreement
Pharming to Directly Commercialise Ruconest in Austria Germany and NetherlandsBiotech company Pharming Group NV ("Pharming" or "the Company") (EURONEXT: PHARM) and Swedish Orphan Biovitrum AB (publ) or "Sobi" (SS: SOBI) today announced the amendment and extension of the Ruconest®...
Press Releases
Therapure Biopharma to Attend BioProcess International Conference & Exhibition
Therapure Biopharma is appearing at the upcoming BioProcess International Conference & Exhibition. The company can be found at booth number 818. The event takes place from Monday 20 October to Thursday 23 October at Hynes Convention...
Press Releases
Boehringer brings Striverdi Respimat to market for COPD treatment in US
Boehringer Ingelheim Pharmaceuticals has introduced Striverdi Respimat (olodaterol) inhalation spray 5µg in the US market. Striverdi Respimat is indicated to treat airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic ...
Press Releases
Pharma ‘cannot deliver patient centricity’
Eyeforpharma, London, September 2014: Mary Baker, immediate past President of the European Brain Council, believes that pharma companies are focusing too much on patient centricity and instead, should widen their focus to include the whole...
Press Releases
Grupo Juste to supply D&A Pharma’s Alcover in Spain and Central America
France-based D&A Pharma has entered into an exclusive supply, licensing and distribution agreement with Grupo Juste for Alcover, sodium oxybate, a treatment for alcohol dependence. As part of the deal, Grupo Juste will...
Press Releases
Pfanstiehl Launches cGMP-produced Mannose for Cell Culture Media Optimization and Glycoprotein Biosynthesis
Pfanstiehl has announced the launch of cGMP-produced, high purity Mannose (USP/NF, EP), manufactured in the US under ICH Q7 compliant conditions. "Mannose has long been recognized for playing a key role in protein...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read